EcoDrugPlus

Ensembl ID : ENSTNIG00000002139
Gene Symbol: -
1 Cross references
85 Possible Orthologues:

Ensembl ID : ENSTNIG00000002141
Gene Symbol: -
1 Cross references
85 Possible Orthologues:

Ensembl ID : ENSTNIG00000002250
Gene Symbol: -
1 Cross references
48 Possible Orthologues:

Ensembl ID : ENSTNIG00000002281
Gene Symbol: -
1 Cross references
48 Possible Orthologues:

Ensembl ID : ENSTNIG00000005122
Gene Symbol: -
1 Cross references
85 Possible Orthologues:

Ensembl ID : ENSTNIG00000008277
Gene Symbol: -
1 Cross references
98 Possible Orthologues:

Ensembl ID : ENSTNIG00000013464
Gene Symbol: -
1 Cross references
5 Possible Orthologues:

Ensembl ID : ENSTNIG00000014911
Gene Symbol: PRKCI
2 Cross references
87 Possible Orthologues:

Ensembl ID : ENSTNIG00000019719
Gene Symbol: RPL19
2 Cross references
13 Possible Orthologues:

Ensembl ID : ENSTNIG00000005493
Gene Symbol: -
1 Cross references
193 Possible Orthologues:

Ensembl ID : ENSTNIG00000009229
Gene Symbol: -
1 Cross references
215 Possible Orthologues:

Ensembl ID : ENSTNIG00000012427
Gene Symbol: -
1 Cross references
108 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).